tiprankstipranks
Advertisement
Advertisement

MGNX Stock Latest News

MacroGenics price target raised to $4 from $3 at Barclays
The FlyMacroGenics price target raised to $4 from $3 at Barclays
17d ago
MGNX
FDA Places Partial Clinical Hold on MacroGenics Trial
PremiumCompany Announcements
FDA Places Partial Clinical Hold on MacroGenics Trial
1M ago
8K
MGNX
MacroGenics says FDA places partial clinical hold on Phase 2 LINNET study
PremiumThe Fly
MacroGenics says FDA places partial clinical hold on Phase 2 LINNET study
1M ago
MGNX
MacroGenics Inc (MGNX) Q4 Earnings Cheat Sheet
PremiumPre-Earnings
MacroGenics Inc (MGNX) Q4 Earnings Cheat Sheet
1M ago
MGNX
MacroGenics Announces Departure of Chief Medical Officer
PremiumCompany Announcements
MacroGenics Announces Departure of Chief Medical Officer
4M ago
8K
MGNX
MacroGenics, Inc. Reports Decline in Quarterly Revenues
PremiumCompany AnnouncementsMacroGenics, Inc. Reports Decline in Quarterly Revenues
4M ago
MGNX
Strategic Shift and Transitional Phases Lead to Hold Rating for MacroGenics
Premium
Ratings
Strategic Shift and Transitional Phases Lead to Hold Rating for MacroGenics
4M ago
MGNX
MacroGenics reports Q3 EPS 27c vs 90c last year
Premium
The Fly
MacroGenics reports Q3 EPS 27c vs 90c last year
4M ago
MGNX
MacroGenics expects cash to fund operations into late 2027
PremiumThe Fly
MacroGenics expects cash to fund operations into late 2027
4M ago
MGNX
MGNX Earnings this Week: How Will it Perform?
PremiumPre-Earnings
MGNX Earnings this Week: How Will it Perform?
5M ago
MGNX
MacroGenics Advances in Cancer Treatment with MGC028 Clinical Trial
PremiumCompany Announcements
MacroGenics Advances in Cancer Treatment with MGC028 Clinical Trial
5M ago
MGNX
MacroGenics’ Lorigerlimab Study: A Potential Game-Changer in Cancer Treatment?
PremiumCompany Announcements
MacroGenics’ Lorigerlimab Study: A Potential Game-Changer in Cancer Treatment?
5M ago
MGNX
MacroGenics’ MGC026 Study: A New Hope for Advanced Cancer Treatment
PremiumCompany AnnouncementsMacroGenics’ MGC026 Study: A New Hope for Advanced Cancer Treatment
5M ago
MGNX
MacroGenics’ MGD024 Study: A New Hope for Blood Cancer Treatment?
Premium
Company Announcements
MacroGenics’ MGD024 Study: A New Hope for Blood Cancer Treatment?
5M ago
MGNX
MacroGenics assumed with an Overweight at Barclays
Premium
The Fly
MacroGenics assumed with an Overweight at Barclays
6M ago
MGNX
MacroGenics initiated with an Overweight at Barclays
PremiumThe Fly
MacroGenics initiated with an Overweight at Barclays
6M ago
MGNX
MacroGenics’ Strategic Shift and Lorigerlimab’s Trial Impact: A Hold Rating Amid CEO Transition and Drug Development Uncertainty
PremiumRatings
MacroGenics’ Strategic Shift and Lorigerlimab’s Trial Impact: A Hold Rating Amid CEO Transition and Drug Development Uncertainty
7M ago
MGNX
MacroGenics price target lowered to $5 from $8 at Leerink
PremiumThe Fly
MacroGenics price target lowered to $5 from $8 at Leerink
7M ago
MGNX
MacroGenics Inc. Reports Q2 2025 Financial Results
PremiumCompany Announcements
MacroGenics Inc. Reports Q2 2025 Financial Results
7M ago
MGNX
Closing Bell Movers: UnitedHealth jumps 10% as Berkshire, Appaloosa buy weakness
PremiumThe FlyClosing Bell Movers: UnitedHealth jumps 10% as Berkshire, Appaloosa buy weakness
7M ago
NUE
UNH
MacroGenics reports Q2 EPS (57c), consensus (38c)
Premium
The Fly
MacroGenics reports Q2 EPS (57c), consensus (38c)
7M ago
MGNX
MacroGenics’ MGC026 Study: A New Hope for Advanced Solid Tumors?
Premium
Company Announcements
MacroGenics’ MGC026 Study: A New Hope for Advanced Solid Tumors?
7M ago
MGNX

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >